McKesson Total Assets 2010-2022 | MCK

McKesson total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • McKesson total assets for the quarter ending March 31, 2022 were $63.298B, a 2.64% decline year-over-year.
  • McKesson total assets for 2022 were $63.298B, a 2.64% decline from 2021.
  • McKesson total assets for 2021 were $65.015B, a 6.15% increase from 2020.
  • McKesson total assets for 2020 were $61.247B, a 2.64% increase from 2019.
McKesson Annual Total Assets
(Millions of US $)
2022 $63,298
2021 $65,015
2020 $61,247
2019 $59,672
2018 $60,381
2017 $60,969
2016 $56,523
2015 $53,870
2014 $51,759
2013 $34,786
2012 $33,093
2011 $30,886
2010 $28,189
2009 $25,267
McKesson Quarterly Total Assets
(Millions of US $)
2022-03-31 $63,298
2021-12-31 $63,708
2021-09-30 $63,601
2021-06-30 $62,894
2021-03-31 $65,015
2020-12-31 $61,845
2020-09-30 $61,558
2020-06-30 $57,666
2020-03-31 $61,247
2019-12-31 $60,873
2019-09-30 $58,994
2019-06-30 $61,680
2019-03-31 $59,672
2018-12-31 $61,011
2018-09-30 $61,421
2018-06-30 $61,282
2018-03-31 $60,381
2017-12-31 $64,213
2017-09-30 $63,846
2017-06-30 $61,816
2017-03-31 $60,969
2016-12-31 $57,874
2016-09-30 $58,315
2016-06-30 $57,904
2016-03-31 $56,523
2015-12-31 $55,087
2015-09-30 $55,819
2015-06-30 $55,925
2015-03-31 $53,870
2014-12-31 $55,110
2014-09-30 $52,232
2014-06-30 $53,006
2014-03-31 $51,759
2013-12-31 $36,479
2013-09-30 $35,947
2013-06-30 $35,491
2013-03-31 $34,786
2012-12-31 $33,433
2012-09-30 $32,968
2012-06-30 $31,748
2012-03-31 $33,093
2011-12-31 $33,157
2011-09-30 $31,907
2011-06-30 $31,017
2011-03-31 $30,886
2010-12-31 $30,396
2010-09-30 $26,792
2010-06-30 $27,399
2010-03-31 $28,189
2009-12-31 $27,539
2009-09-30 $26,624
2009-06-30 $25,717
2009-03-31 $25,267
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $46.288B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.676B 20.41
AmerisourceBergen (ABC) United States $29.474B 13.60
West Pharmaceutical Services (WST) United States $22.672B 34.54
Laboratory Of America Holdings (LH) United States $22.247B 9.29
Cooper (COO) United States $15.585B 23.99
Cardinal Health (CAH) United States $14.234B 10.93
CONMED (CNMD) United States $2.863B 29.57
Invacare (IVC) United States $0.048B 0.00